Analystreport

Epizyme Inc (NASDAQ: EPZM) had its "buy" rating re-affirmed by analysts at Cann. They now have a $27.00 price target on the stock.

Epizyme, Inc.  (EPZM) 
Last epizyme, inc. earnings: 2/24 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: epizyme.com